Actively Recruiting
Cohort Study of Intrauterine Diseases
Led by Wenwen Wang · Updated on 2025-07-02
2000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on uterine cavity diseases, which include a range of hormone-related gynecological conditions such as endometrial hyperplasia, endometrial polyps, and endometrial malignancies. These conditions affect women's reproductive health and quality of life, with some types potentially leading to cancer. The study aims to build a research platform that connects clinical practice with scientific investigation to better understand the causes, risk factors, and treatments for these diseases. The study uses a prospective cohort design without any treatment intervention. Participants diagnosed with uterine cavity diseases and undergoing hysteroscopic surgery or diagnostic curettage will be enrolled. After surgery, the researchers will follow participants for one year, conducting assessments every three months to monitor disease progression and recurrence of conditions like endometrial polyps or hyperplasia. Participants will provide detailed medical histories, undergo physical and gynecological exams, imaging, lab tests, and pathological examinations. Follow-up visits will track disease changes and outcomes over a year. The primary outcome is to observe the recurrence of specific uterine conditions. This comprehensive approach aims to gather clinical data to improve understanding and management of uterine cavity diseases.
CONDITIONS
Brief Title
Cohort Study of Intrauterine Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- Patients needing hysteroscopy or diagnostic curettage for uterine cavity diseases such as endometrial hyperplasia, polyps, submucosal fibroids, adenomyosis, or malignancies
- Willing and able to follow study visit and follow-up requirements
- Signed informed consent obtained
You will not qualify if you...
- Currently participating in other drug clinical trials
- Unable or not allowed to undergo hysteroscopy or curettage procedures
- Unwilling or unable to provide informed consent
- Unwilling or unable to follow study protocols
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during which eligibility for hysteroscopy or diagnostic curettage is assessed
Duration - Up to 1 day
Participants undergo hysteroscopy or diagnostic curettage to assess uterine cavity diseases such as endometrial hyperplasia, polyps, or malignancies.
1 visit for hysteroscopy or diagnostic curettage
Duration - 1 year
Participants are followed after diagnostic procedures to monitor recurrence of endometrial polyps or hyperplasia and other outcomes.
Follow-up visits every 3 months for 1 year after hysteroscopic surgery
Trial Site Locations
Total: 1 location
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
W
Wen W Wang, Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here